25 Apr 2022 , 03:40 PM
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies innovative marketing and sales solutions in the MENA (Middle East & North Africa) region. The Company supplies these products in the UAEand other neighboring countries.
In the UAE market, the company supplies products through the Dubai Health Authority (DHA). It has market authorizations by the UAE regulatory authorities for various products. For the year ended December 2021, Access Healthcare for Medical Products posted revenues of AED 12 Mn (Rs250 million) and a profit after tax of AED 4.5 Mn (Rs94 million). The company has no debt on its books.
Commenting on the transaction, Mark Saldanha, Promoter & Managing Director of Marksans Pharma said “We are delighted to welcome Access Health to the Marksans family. Gaining access to key global markets is one of our strategic pillars to enhance shareholder value. Access Health brings deep knowledge of the Middle East and North African (MENA) region, an experienced sales and marketing team, a strong network of distributors and regulatory expertise.
This acquisition strengthens our presence and market-access in the region. We remain committed to our goal of reaching Rs2,000 crore in revenues, improving our margins over the next couple of years and delivering superior returns for our shareholders”.
This deal will enable Marksans to use the front-end sales and marketing infrastructure of Access Healthcare for marketing its products manufactured in the India, UK, and USA regions. It will bolster Marksans’ presence in the Middle East and North African regions by leveraging Access Health’s knowledge of local business cultures and access to a network of partners and distributors in those regions.
The shareholders of Access Healthcare will receive a cash consideration of AED 13 Mn (Rs271 million) on closure of the transaction, which is subject to regulatory approvals. The transaction will be funded from internal accruals.
Marksans Pharma ended at Rs54.25 apiece down by Rs1.55 or 2.78% on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.